In short, global GLCCI1 knockout in Dex-treated asthmatic mice could reduce GR and GRIP1 expression, decreasing the less binding of GRIP1 to GR, which finally reduced Dex anti-inflammatory responses and led to GC insensitivity in asthma. The gene discussed is GLCCI1; the disease is asthma.